Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10721 (
c-kit
)
6,575
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Definitive hematopoiesis starts in the aorta-gonad-mesonephros (AGM) region of the mouse embryo. Our previous studies revealed that STAT3, a gp130 downstream transcription factor, is required for AGM hematopoiesis and that
homeodomain-interacting protein kinase 2
(
HIPK2
) phosphorylates serine-727 of STAT3.
HIPK2
is a serine/threonine kinase known to be involved in transcriptional repression and apoptosis. In the present study, we examined the role of
HIPK2
in hematopoiesis in mouse embryo.
HIPK2
transcripts were found in fetal hematopoietic tissues such as the mouse AGM region and fetal liver. In cultured AGM cells,
HIPK2
protein was detected in adherent cells. Functional analyses of
HIPK2
were carried out by introducing wild-type and mutant
HIPK2
constructs into AGM cultures. Production of CD45(+) hematopoietic cells was suppressed by forced expression of
HIPK2
in AGM cultures. This suppression required the kinase domain and nuclear localization signals of
HIPK2
, but the kinase activity was dispensable.
HIPK2
-overexpressing AGM-derived nonadherent cells did not form cobblestone-like colonies in cultures with stromal cells. Furthermore, overexpression of
HIPK2
in AGM cultures impeded the expansion of CD45(low)
c-Kit
(+) cells, which exhibit the immature hematopoietic progenitor phenotype. These data indicate that
HIPK2
plays a negative regulatory role in AGM hematopoiesis in the mouse embryo.
...
PMID:Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis. 1706 87